Evidence map›Paper›PMID 33257880›Full record

ReviewNature human behaviour2021

Improving the precision of intranasal oxytocin research.

Adriano Winterton, Lars T Westlye, Nils Eiel Steen, Ole A Andreassen, Daniel S Quintana

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature human behaviour, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Trial
  6. Divergent effects of oxytocin on "mind-reading" in healthy males.Cognitive, affective & behavioral neuroscience · 2022
    Trial
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Oxytocin-a social peptide? Deconstructing the evidence.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  20. Frontiers in behavioral neuroscience · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Adriano WintertonNORMENT, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-8678-3610
Lars T WestlyeNORMENT, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-8644-956X
Nils Eiel SteenNORMENT, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0001-6442-1179
Ole A AndreassenNORMENT, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway.ORCID http://orcid.org/0000-0002-4461-3568
Daniel S QuintanaNORMENT, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway. daniel.quintana@medisin.uio.no.ORCID http://orcid.org/0000-0003-2876-0004

Funding

Norges Forskningsråd (Research Council of Norway) 301767Novo Nordisk Fonden (Novo Nordisk Foundation) NNF16OC0019856
6 · The paper itself

Abstract

The neuropeptide oxytocin has been popularized for its role in social behaviour and nominated as a candidate treatment for several psychiatric illnesses due to promising preclinical results. However, these results so far have failed to reliably translate from animal models to human research. In response, there have been justified calls to improve intranasal oxytocin delivery methodology in terms of verifying that intranasal administration increases central levels of oxytocin. Nonetheless, improved methodology needs to be coupled with a robust theory of the role of oxytocin in behaviour and physiology to ask meaningful research questions. Moreover, stringent methodology based on robust theory may yield interesting results, but such findings will have limited utility if they are not reproducible. We outline how the precision of intranasal oxytocin research can be improved by the complementary consideration of methodology, theory and reproducibility.

Indexed as

Administration, IntranasalAnimalsHumansMental DisordersOxytocinQuality ImprovementReceptors, OxytocinReproducibility of ResultsTranslational Research, BiomedicalOxytocinReceptors, Oxytocin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.